Molecular diagnosis and modern management of Duchenne muscular dystrophy.
The increased understanding of the genetic basis for DMD and the pathophysiology of the disease have produced improved techniques of patient and carrier diagnosis, genetic counseling, and new approaches to searching for a treatment. The present level of experimentation with both myoblast implantation and gene therapy may make treatment of this inherited, relentlessly progressive muscle disease possible within the next several years.
Department of Neurology, California Pacific Medical Center, San Francisco.
R G
RG
Miller
E P
EP
Hoffman
D000328:Adult; D000818:Animals; D004247:DNA / Q000032:analysis; D016189:Dystrophin / Q000032:analysis; D005260:Female; D005817:Genetic Counseling; D005820:Genetic Testing; D015316:Genetic Therapy; D006579:Heterozygote; D006801:Humans; D007165:Immunosuppression Therapy; D007231:Infant, Newborn; D008297:Male; D018482:Muscle, Skeletal / Q000637:transplantation; D009136:Muscular Dystrophies / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy; D010375:Pedigree
D016189:Dystrophin; D004247:DNA